Industry reports
Editor highlights

Cancer Vaccine Research Reports, April 2014

You might be interested in: cancer, therapeutics, vaccine, more »


 

1-10 of about 100 reports for Cancer Vaccine
Analytical Tool - Cancer Vaccines

Analytical Tool - Cancer Vaccines

  • $ 4 650
  • Industry report
  • March 2014
  • by Bioseeker

... Products & key areas of pharmaceutical r&d*this software application is a searchable database reflects the most recent advances in the field of cancer vaccine drug development, in order to help you ...

Cancer Vaccines Drug Pipeline Update 2014

Cancer Vaccines Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

... cancer vaccines drug pipeline update 2014 cancer vaccines offer an attractive therapeutic addition, delivering treatment of high specificity, low toxicity and prolonged activity. However, despite ...

Competitor Analysis: Cancer Vaccines

Competitor Analysis: Cancer Vaccines

  • $ 1 056
  • Industry report
  • March 2014
  • by La Merie Publishing

... Competitor analysis: cancer vaccines cancer vaccines the present competitive intelligence report about cancer vaccines provides a competitor evaluation in the field of novel ...

Radient Pharmaceuticals Corporation (RDNT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Radient Pharmaceuticals Corporation (RDNT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • March 2014
  • by Global Data

... Is a proprietary ivd cancer test. It offers screening, monitoring and detection of 19 or more types of cancers. The company also commercializes a proprietary cancer vaccine therapy technology: combined immunogene ...

KAEL-GemVax Co., Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

KAEL-GemVax Co., Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • February 2014
  • by Global Data

... Healthcare, deal details 9asset purchase 9affitech completes sale of its remaining rights of cancer vaccine to gemvax 9acquisition 10gemvax & kael completes acquisition of remaining stake ...

Biovest International, Inc. (BVTI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Biovest International, Inc. (BVTI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Industry report
  • February 2014
  • by Global Data

... Manufacturing and sale of autovaxid and other instruments and consumables; and commercial production of cell culture products and services. Biovaxid is an under development patient-specific therapeutic cancer ...

BioSante Pharmaceuticals, Inc. (ANIP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

BioSante Pharmaceuticals, Inc. (ANIP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Industry report
  • February 2014
  • by Global Data

... Develops of cancer vaccines, with phase i and phase ii clinical trials on-going. Biosante is headquartered in lincolnshire, illinois, the us.Biosante pharmaceuticals, inc. (Anip) - pharmaceuticals ...

Bio-Bridge Science, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Bio-Bridge Science, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Industry report
  • February 2014
  • by Global Data

... Serum, which is a major production material in producing vaccines. The company owns the license of papillomavirus pseudovirus technology (original vaccine technology) for the hiv vaccine and colon cancer ...

Targovax AS - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Targovax AS - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • January 2014
  • by Global Data

... In the field of oncology. It develops therapeutic anti-cancer vaccines. Targovax's product cand, tg01, is a peptide vaccine that targets mutations in the ras genes associated with cancer. The company's tg01 ...

Vaccinogen, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Vaccinogen, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • January 2014
  • by Global Data

... The development and commercialization of cancer vaccines and other immunotherapeutics products. Its product includes oncovax. Vaccinogen products are used in the treatment of cancer, infectious disease, autoimmune ...


» Read our Company Profiles

1 Companies for Cancer Vaccine

GlaxoSmithKline P.L.C.

United States

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.